BioSpace News Archive

GenScript Biotech Corporation’s CDMO business GenScript ProBio (hereinafter referred to as GenScript ProBio) and Eutilex Co., Ltd. (hereinafter referred to as Eutilex) committed to developing anti-cancer immunotherapy technology jointly announced that the parties entered into strategic collaboration

Following Surge of Interest in Remote Care Platform and Success of COVID-19 Solution, Datos to Accelerate Sales, Marketing and Execution of Comprehensive Product Roadmap

SenesTech, Inc. announced the Company’s support of the efforts by community health officials and business leaders to respond with aggressive programs to control high rat populations that are emerging during the COVID-19 pandemic.

CyberMDX, a leading healthcare cybersecurity provider delivering visibility, threat prevention, and operational efficiency for medical devices, IoT, and clinical networks, announced today it secured $20 million in funding, bringing its fundraising total to $30 million.

The COVID-19 Pandemic has drastically changed which products and services are being bought and how they are being purchased.

TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today that it will offer academic institutions free access to TrialAssure REGISTRY—the premiere clinical trial disclosure reporting application.

Nuvera Life Science Consulting, an expert advisor on patient-centric experience strategies for specialty therapeutics, has launched The PURE Report: Neurology 2020

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that it has been granted a patent on its Bio-RFID technology.

NANO-X IMAGING LTD (https://www.nanox.vision/) (“Nanox” or the “Company”), an innovative medical imaging company, announces its collaboration with Qure.ai (http://qure.ai/), a leading healthcare AI startup, to integrate Qure.ai’s diagnostics solution into Nanox’s planned cloud-based software platform, the Nanox.CLOUD.

Fundación MAPFRE, a global nonprofit foundation created by MAPFRE, announced it will donate $2.3 million to support urgent medical and community needs across Massachusetts, as the coronavirus continues to spread.